Patents Assigned to BIOFIDELITY LTD
  • Patent number: 11999996
    Abstract: A method of detecting a target polynucleotide sequence in a given nucleic acid analyte characterised by the steps of: a. annealing the analyte to a single-stranded probe oligonucleotide A0 to create a first intermediate product which is at least partially double-stranded and in which the 3? end of A0 forms a double-stranded complex with the analyte target sequence; b. pyrophosphorolysing the first intermediate product with a pyrophosphorolysing enzyme in the 3?-5? direction from the 3? end of A0 to create partially digested strand A1 and the analyte; c. (i) annealing A1 to a single-stranded trigger oligonucleotide B and extending the A1 strand in the 5?-3? direction against B; or (ii) circularising A1 through ligation of its 3? and 5? ends; or (iii) ligating the 3? end of A1 to the 5? end of a ligation probe oligonucleotide C; in each case to create an oligonucleotide A2; d. priming A2 with at least one single-stranded primer oligonucleotide and creating multiple copies of A2, or a region of A2; and e.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: June 4, 2024
    Assignee: BIOFIDELITY LTD
    Inventors: Barnaby Balmforth, Cameron Frayling, Ana Silva-Weatherley, Magdalena Stolarek-Januszkiewicz
  • Publication number: 20230129793
    Abstract: Provided herein are kits and devices which may be used for improved polynucleotide detection.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 27, 2023
    Applicant: Biofidelity Ltd
    Inventors: Cameron Alexander FRAYLING, Magdalena STOLAREK-JANUSZKIEWICZ, Barnaby William BALMFORTH
  • Patent number: 11332780
    Abstract: Methods of detecting target polynucleotide sequences may include introducing one or more nucleic acid analytes to a first reaction mixture comprising a single-stranded probe oligonucleotide A0, a pyrophosphorolysing enzyme, and a ligase. The analyte may anneal to the single-stranded probe oligonucleotide A0 to create a first intermediate product which is at least partially double-stranded, where the 3? end of A0 forms a double-stranded complex with the analyte and where A0 is pyrophosphorylsed in the 3?-5? direction from the 3? end to create at least a partially digested strand A1. A1 may undergo ligation to form oligonucleotide A2. The methods may also include detecting a signal derived from the formed oligonucleotides, and inferring therefrom the presence or absence of the target polynucleotide sequence in the analyte.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: May 17, 2022
    Assignee: BIOFIDELITY LTD
    Inventors: Barnaby Balmforth, Magdalena Stolarek-Januszkiewicz, Ana Silva-Weatherley, Paulina Powalowska
  • Publication number: 20210189478
    Abstract: Methods of detecting target polynucleotide sequences may include introducing one or more nucleic acid analytes to a first reaction mixture comprising a single-stranded probe oligonucleotide A0, a pyrophosphorolysing enzyme, and a ligase. The analyte may anneal to the single-stranded probe oligonucleotide A0 to create a first intermediate product which is at least partially double-stranded, where the 3? end of A0 forms a double-stranded complex with the analyte and where A0 is pyrophosphorylsed in the 3?-5? direction from the 3? end to create at least a partially digested strand A1. A1 may undergo ligation to form oligonucleotide A2. The methods may also include detecting a signal derived from the formed oligonucleotides, and inferring therefrom the presence or absence of the target polynucleotide sequence in the analyte.
    Type: Application
    Filed: June 25, 2020
    Publication date: June 24, 2021
    Applicant: BIOFIDELITY LTD
    Inventors: Barnaby BALMFORTH, Magdalena STOLAREK-JANUSZKIEWICZ, Ana SILVA-WEATHERLEY, Paulina POWALOWSKA
  • Publication number: 20210180122
    Abstract: A method of detecting a target polynucleotide sequence in a given nucleic acid analyte characterised by the steps of: a. annealing the analyte to a single-stranded probe oligonucleotide A0 to create a first intermediate product which is at least partially double-stranded and in which the 3? end of A0 forms a double-stranded complex with the analyte target sequence; b. pyrophosphorolysing the first intermediate product with a pyrophosphorolysing enzyme in the 3?-5? direction from the 3? end of A0 to create partially digested strand A1 and the analyte; c. (i) annealing A1 to a single-stranded trigger oligonucleotide B and extending the A1 strand in the 5?-3? direction against B; or (ii) circularising A1 through ligation of its 3? and 5? ends; or (iii) ligating the 3? end of A1 to the 5? end of a ligation probe oligonucleotide C; in each case to create an oligonucleotide A2; d. priming A2 with at least one single-stranded primer oligonucleotide and creating multiple copies of A2, or a region of A2; and e.
    Type: Application
    Filed: February 22, 2021
    Publication date: June 17, 2021
    Applicant: BIOFIDELITY LTD
    Inventors: Barnaby BALMFORTH, Cameron FRAYLING, Ana SILVA-WEATHERLEY, Magdalena STOLAREK-JANUSZKIEWICZ
  • Patent number: 10961569
    Abstract: A method of detecting a target polynucleotide sequence in a given nucleic acid analyte characterised by the steps of: a. annealing the analyte to a single-stranded probe oligonucleotide A0 to create a first intermediate product which is at least partially double-stranded and in which the 3? end of A0 forms a double-stranded complex with the analyte target sequence; b. pyrophosphorolysing the first intermediate product with a pyrophosphorolysing enzyme in the 3?-5? direction from the 3? end of A0 to create partially digested strand A1 and the analyte; c. (i) annealing A1 to a single-stranded trigger oligonucleotide B and extending the A1 strand in the 5?-3? direction against B; or (ii) circularising A1 through ligation of its 3? and 5? ends; or (iii) ligating the 3? end of A1 to the 5? end of a ligation probe oligonucleotide C; in each case to create an oligonucleotide A2; d. priming A2 with at least one single-stranded primer oligonucleotide and creating multiple copies of A2, or a region of A2; and e.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: March 30, 2021
    Assignee: BIOFIDELITY LTD
    Inventors: Barnaby Balmforth, Cameron Frayling, Ana Silva-Weatherley, Magdalena Stolarek-Januszkiewicz